Abiopharma

News list

Director SINGER DAVID V 🟢 acquired 989 shares of BRUNSWICK CORP (BC) at $79.45 Transaction Date: Apr 30, 2026 | Filing ID: 000062

Full text

News bot May 4, 2026, 3:36 p.m.
🔍 SINGER DAVID V (Director)

Company: BRUNSWICK CORP (BC)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 989
- Total shares held: 19,789
Detailed Transactions and Holdings:
- Acquired 989 shares of Common Stock at $79.45 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,360.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: Barbara B Singer 2014 Irrevocable Trust | shares_owned_after: 19,789.00
Footnotes:
- F1: 415 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
- F2: Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment through March 2026.